Literature DB >> 3279829

The right to refuse treatment with antipsychotic medications: retrospect and prospect.

P S Appelbaum1.   

Abstract

The right to refuse antipsychotic medication is now more than a decade old. Its evolution has taken divergent forms, driven either by the needs of patients' treatment or the mandate of patients' rights. Regardless of the model employed, refusal is not uncommon, but refusing patients appear almost always to receive treatment in the end. These findings point up the essential illogic of allowing committed persons to refuse treatment that would permit their freedom to be restored. The future evolution of the right may proceed differently in federal and state courts, but whether at the level of legal theory or actual practice, some accommodation will restore the equivalence between the power to commit and the power to treat.

Entities:  

Keywords:  Analytical Approach; Legal Approach; Mental Health Therapies; Professional Patient Relationship

Mesh:

Substances:

Year:  1988        PMID: 3279829     DOI: 10.1176/ajp.145.4.413

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  6 in total

1.  Ethical issues in community mental health: cases and conflicts.

Authors:  R C Christensen
Journal:  Community Ment Health J       Date:  1997-02

2.  Anticipatory planning for psychiatric treatment is not quite the same as planning for end-of-life care.

Authors:  P Backlar
Journal:  Community Ment Health J       Date:  1997-08

3.  The right to refuse treatment: an uncertain future.

Authors:  G B Leong; J A Silva
Journal:  Psychiatr Q       Date:  1988

4.  The PSDA and treatment refusal by a depressed older patient committed to the state mental hospital.

Authors:  M A Lee; L Ganzini; R Heintz
Journal:  HEC Forum       Date:  1993-09

5.  Clozapine rationing in a state mental hospital: reviewing a HEC's case consultation.

Authors:  P Backlar; B H McFarland
Journal:  HEC Forum       Date:  1993-09

6.  Marginal capacity: the dilemmas faced in assessment and declaration.

Authors:  V Ho
Journal:  CMAJ       Date:  1995-01-15       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.